BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 0.06% -1.91% 14.30% 2.28% 73.28% 14.74% -1.02% -- 16.23% 04/07/2010
BIB Market Price 0.13% -1.80% 14.32% 2.32% 73.45% 14.71% -1.06% -- 16.23% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $78,296,117
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/13/2026
  • NAV
    $86.04
  • NAV Change
    $+0.87 up caret
  • Market Price
    $86.00
  • Market Price Change
    $+0.91 up caret
  • Trading Volume (M)
    4,630
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $78,296,117
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 5/13/2026
  • NAV
    $86.04
  • NAV Change
    $+0.87 up caret
  • Market Price
    $86.00
  • Market Price Change
    $+0.91 up caret
  • Trading Volume (M)
    4,630
  • 30-Day Median Bid Ask Spread
    0.24%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2026

Holdings

as of 5/13/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.76% VRTX VERTEX PHARMACEUTICALS INC -- $3,724,606.26 8,221 2931034
4.66% GILD GILEAD SCIENCES INC -- $3,648,497.10 27,422 2369174
4.52% AMGN AMGEN INC -- $3,540,463.35 10,523 2023607
3.79% REGN REGENERON PHARMACEUTICALS -- $2,968,785.12 4,124 2730190
1.96% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,534,350.72 5,264 B00FWN1
1.52% BIIB BIOGEN INC -- $1,191,387.25 5,825 2455965
1.51% RVMD REVOLUTION MEDICINES INC -- $1,179,428.04 7,866 BL71K91
1.29% INSM INSMED INC -- $1,009,522.44 8,556 2614487
1.29% UTHR UNITED THERAPEUTICS CORP -- $1,008,399.60 1,740 2430412
1.16% RPRX ROYALTY PHARMA PLC- CL A -- $905,516.25 17,005 BMVP7Y0
1.15% ARGX ARGENX SE - ADR -- $903,840.20 1,126 BDVLM39
1.12% ILMN ILLUMINA INC -- $880,005.00 6,069 2613990
1.06% ROIV ROIVANT SCIENCES LTD -- $830,081.76 28,408 BMW4NZ9
1.01% VTRS VIATRIS INC -- $793,826.37 45,701 BMWS3X9
1.01% MRNA MODERNA INC -- $790,383.92 15,676 BGSXTS3
1.00% INCY INCYTE CORP -- $780,579.18 7,899 2471950
0.82% NBIX NEUROCRINE BIOSCIENCES INC -- $642,698.88 3,984 2623911
0.76% ASND ASCENDIS PHARMA A/S -- $595,309.52 2,444 BWXJHM8
0.74% SMMT SUMMIT THERAPEUTICS INC -- $578,281.04 30,776 BMTVQS7
0.72% JAZZ JAZZ PHARMACEUTICALS PLC -- $567,582.19 2,443 B4Q5ZN4
0.68% EXEL EXELIXIS INC -- $528,697.32 10,308 2576941
0.67% BBIO BRIDGEBIO PHARMA INC -- $527,953.95 7,695 BK1KWG8
0.65% GH GUARDANT HEALTH INC -- $512,634.82 5,206 BFXC911
0.65% IONS IONIS PHARMACEUTICALS INC -- $508,823.20 6,557 BDJ0LS6
0.61% AXSM AXSOME THERAPEUTICS INC -- $477,699.60 2,030 BYZR4X4
0.61% MEDP MEDPACE HOLDINGS INC -- $477,577.52 1,127 BDCBC61
0.60% MDGL MADRIGAL PHARMACEUTICALS INC -- $472,690.57 911 BD59BS7
0.55% ARWR ARROWHEAD PHARMACEUTICALS IN -- $432,857.04 5,558 BYQBFJ8
0.53% BNTX BIONTECH SE-ADR -- $417,340.75 4,525 BK6H543
0.53% SNY SANOFI-ADR -- $412,110.30 9,715 2964557
0.52% BMRN BIOMARIN PHARMACEUTICAL INC -- $408,800.70 7,634 2437071
0.51% ONC BEONE MEDICINES LTD-ADR -- $401,701.95 1,269 BYYWPW6
0.49% PRAX PRAXIS PRECISION MEDICINES I -- $383,258.20 1,105 BQ721R4
0.48% CYTK CYTOKINETICS INC -- $377,528.58 4,889 BBBSBJ5
0.46% KRYS KRYSTAL BIOTECH INC -- $362,592.80 1,160 BD6JX35
0.42% IBRX IMMUNITYBIO INC -- $332,585.20 40,808 BNSP0B8
0.42% HALO HALOZYME THERAPEUTICS INC -- $328,020.52 4,684 2975098
0.40% TEM TEMPUS AI INC-CL A -- $316,526.40 6,896 BSLSJJ0
0.40% PCVX VAXCYTE INC -- $309,930.25 5,713 BKPVGH6
0.39% NUVL NUVALENT INC-A -- $305,664.10 2,905 BMVBZD3
0.38% ABVX ABIVAX SA-ADR -- $297,338.49 2,439 BLC89B2
0.35% KYMR KYMERA THERAPEUTICS INC -- $277,397.19 3,241 BMPRZV5
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $263,128.04 2,533 BDCBCD8
0.33% MIRM MIRUM PHARMACEUTICALS INC -- $261,438.20 2,395 BJDX8Y8
0.33% ALKS ALKERMES PLC -- $257,389.65 6,615 B3P6D26
0.32% RYTM RHYTHM PHARMACEUTICALS INC -- $253,981.20 2,710 BF2YWG4
0.32% CGON CG ONCOLOGY INC -- $247,974.00 3,351 BRBCSP4
0.31% PTCT PTC THERAPEUTICS INC -- $241,389.56 3,286 B17VCN9
0.30% SYRE SPYRE THERAPEUTICS INC -- $237,858.27 3,117 BQBBDY8
0.30% IMVT IMMUNOVANT INC -- $236,310.75 8,079 BJRFSB7
0.28% COGT COGENT BIOSCIENCES INC -- $220,896.18 6,442 BLR6XK8
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $203,138.33 4,049 BFZQ0L8
0.26% CRSP CRISPR THERAPEUTICS AG -- $200,977.50 3,810 BDHF4K6
0.24% INDV INDIVIOR PHARMACEUTICALS INC -- $190,369.40 4,964 BTZRLN8
0.24% CNTA CENTESSA PHARMACEUTICALS-ADR -- $187,886.26 4,747 BLB0YQ9
0.24% XENE XENON PHARMACEUTICALS INC -- $184,515.76 3,302 BRJ3GY4
0.23% APGE APOGEE THERAPEUTICS INC -- $182,653.44 2,176 BM9HHL5
0.22% LGND LIGAND PHARMACEUTICALS -- $175,198.32 792 2501578
0.22% -- NEWAMSTERDAM PHARMA CO NV -- $172,291.00 4,564 BP8JSP4
0.21% CAI CARIS LIFE SCIENCES INC -- $164,513.31 11,199 BT18HP9
0.21% TVTX TRAVERE THERAPEUTICS INC -- $163,097.55 3,661 BLFGJD5
0.20% CRNX CRINETICS PHARMACEUTICALS IN -- $155,766.88 4,156 BDD19F8
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $154,726.32 12,488 BFNF1D6
0.19% ACAD ACADIA PHARMACEUTICALS INC -- $150,092.06 6,767 2713317
0.18% EWTX EDGEWISE THERAPEUTICS INC -- $143,750.08 4,258 BKY5JZ8
0.17% TNGX TANGO THERAPEUTICS INC -- $136,376.46 5,346 BP2P6L0
0.17% TWST TWIST BIOSCIENCE CORP -- $132,385.26 2,434 BGKG6G7
0.16% BEAM BEAM THERAPEUTICS INC -- $128,769.55 4,043 BK6L288
0.16% ERAS ERASCA INC -- $128,532.48 12,288 BNLYBF3
0.16% ALMS ALUMIS INC -- $124,747.48 5,018 BPLQG36
0.16% DNLI DENALI THERAPEUTICS INC -- $124,641.00 6,295 BD2B4V0
0.16% ORKA ORUKA THERAPEUTICS INC -- $121,368.78 1,921 BKVF0J2
0.15% VCYT VERACYTE INC -- $120,640.50 3,154 BFTWZY0
0.15% DYN DYNE THERAPEUTICS INC -- $120,505.40 6,535 BN15WD1
0.15% GPCR STRUCTURE THERAPEUTICS INC -- $117,743.36 3,092 BQS9486
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $116,895.36 2,276 B72ZBG4
0.14% VERA VERA THERAPEUTICS INC -- $110,872.80 2,832 BL55460
0.14% TARS TARSUS PHARMACEUTICALS INC -- $109,210.74 1,689 BMH5RL1
0.14% KNSA KINIKSA PHARMACEUTICALS INTE -- $107,716.64 1,822 BRXB0C0
0.14% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $106,779.87 4,923 BKX9VD3
0.14% IRON DISC MEDICINE INC -- $106,095.45 1,515 BMGJZJ8
0.13% ELVN ENLIVEN THERAPEUTICS INC -- $102,627.36 2,356 BMFD115
0.13% RARE ULTRAGENYX PHARMACEUTICAL IN -- $101,474.10 3,835 BJ62Z18
0.13% IDYA IDEAYA BIOSCIENCES INC -- $100,745.40 3,486 BK0VHF6
0.13% TXG 10X GENOMICS INC-CLASS A -- $98,417.97 4,671 BKS3RS7
0.12% LEGN LEGEND BIOTECH CORP-ADR -- $96,044.50 3,350 BMX9K07
0.12% KOD KODIAK SCIENCES INC -- $95,975.03 2,423 BFXC933
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $95,568.00 9,955 2100362
0.12% RLAY RELAY THERAPEUTICS INC -- $93,782.68 7,094 BN2R582
0.12% GRAL GRAIL INC -- $93,547.09 1,547 BSLSSX7
0.11% DFTX DEFINIUM THERAPEUTICS INC -- $87,093.57 3,957 BV2DHY6
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $84,606.34 5,278 BFWLC09
0.11% MLYS MINERALYS THERAPEUTICS INC -- $84,367.26 3,141 BP9N0G0
0.11% PHVS PHARVARIS NV -- $83,766.42 2,543 BMZ2X38
0.10% NVCR NOVOCURE LTD -- $81,757.70 4,517 BYSS4X4
0.10% ADMA ADMA BIOLOGICS INC -- $80,350.50 9,453 B9NSBM2
0.10% ADPT ADAPTIVE BIOTECHNOLOGIES -- $80,250.56 6,112 BJ5FZ74
0.10% OCUL OCULAR THERAPEUTIX INC -- $79,842.84 8,641 BNZB1X8
0.10% SRPT SAREPTA THERAPEUTICS INC -- $78,355.56 4,159 B8DPDT7
0.10% TRVI TREVI THERAPEUTICS INC -- $77,724.30 5,090 BJH9ZN0
0.10% TYRA TYRA BIOSCIENCES INC -- $76,650.42 2,118 BMVNDH9
0.10% SION SIONNA THERAPEUTICS INC -- $76,365.52 1,771 BQKXDX4
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $73,135.89 3,501 BN7Q7R7
0.09% ZYME ZYMEWORKS INC -- $72,972.90 2,970 BPCQZY9
0.09% TSHA TAYSHA GENE THERAPIES INC -- $72,516.24 10,872 BNC1BX1
0.09% QURE UNIQURE NV -- $72,137.41 2,473 BJFSR88
0.09% RAPP RAPPORT THERAPEUTICS INC -- $72,047.36 1,892 BR3T9B6
0.09% ANIP ANI PHARMACEUTICALS INC -- $71,983.20 890 BCDWBX6
0.09% STOK STOKE THERAPEUTICS INC -- $71,863.90 2,267 BJQ05Z6
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $70,785.68 2,296 BKSGZN7
0.09% ANAB ANAPTYSBIO INC -- $68,890.82 1,099 BDRW1L7
0.09% INBX INHIBRX BIOSCIENCES INC -- $68,057.15 577 BNSP8K3
0.09% INVA INNOVIVA INC -- $68,031.60 2,940 BDDXF67
0.09% GMAB GENMAB A/S -SP ADR -- $67,835.25 2,555 BBC9WC7
0.09% NTLA INTELLIA THERAPEUTICS INC -- $66,958.92 4,689 BYZM6C2
0.09% AGIO AGIOS PHARMACEUTICALS INC -- $66,919.02 2,326 BCBVTX1
0.09% MBX MBX BIOSCIENCES INC -- $66,825.00 1,782 BQXJKH2
0.08% VCEL VERICEL CORP -- $66,172.60 2,015 BSBMN89
0.08% NRIX NURIX THERAPEUTICS INC -- $66,046.76 4,082 BMVLGP2
0.08% AMLX AMYLYX PHARMACEUTICALS INC -- $63,554.22 4,359 BPCK358
0.08% RXRX RECURSION PHARMACEUTICALS-A -- $63,186.85 20,717 BM9FJ13
0.08% ARDX ARDELYX INC -- $62,102.92 9,734 BN89V40
0.08% ATAI ATAIBECKLEY INC -- $61,128.08 14,417 BWJDYK1
0.08% IOVA IOVANCE BIOTHERAPEUTICS INC -- $59,848.32 16,352 BF0DMK7
0.08% NVAX NOVAVAX INC -- $59,690.41 6,467 BJDQXG4
0.07% PGEN PRECIGEN INC -- $58,282.60 14,044 BKM5C84
0.07% VIR VIR BIOTECHNOLOGY INC -- $58,200.54 6,238 BK4PZ38
0.07% URGN UROGEN PHARMA LTD -- $57,486.52 1,858 BZ7PJQ1
0.07% ABCL ABCELLERA BIOLOGICS INC -- $57,397.41 12,033 BL53SR3
0.07% GLUE MONTE ROSA THERAPEUTICS INC -- $57,372.96 3,026 BP7KZP7
0.07% GHRS GH RESEARCH PLC -- $53,868.56 2,462 BP6C0S2
0.07% KALV KALVISTA PHARMACEUTICALS INC -- $53,760.80 2,006 BD06CS0
0.07% FTRE FORTREA HOLDINGS INC -- $53,698.17 3,711 BRXYZ57
0.07% BCAX BICARA THERAPEUTICS INC -- $52,789.85 2,515 BQB42F1
0.07% WVE WAVE LIFE SCIENCES LTD -- $52,229.28 7,472 BYZG9R0
0.07% CRVS CORVUS PHARMACEUTICALS INC -- $51,923.52 3,278 BYP80F1
0.07% MAZE MAZE THERAPEUTICS INC -- $51,493.60 1,910 BSRK699
0.06% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $50,401.95 1,741 BLCD809
0.06% ALVO ALVOTECH SA -- $48,113.70 13,110 BPNTJ34
0.06% AVBP ARRIVENT BIOPHARMA INC -- $47,416.27 1,639 BMGTLY5
0.06% EYPT EYEPOINT INC -- $44,130.98 3,286 BMGS7L1
0.06% SEPN SEPTERNA INC -- $43,980.75 1,777 BQNKXX2
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $43,936.20 1,260 BX7RSN3
0.06% HROW HARROW INC -- $43,842.75 1,470 BHNDW86
0.06% OLMA OLEMA PHARMACEUTICALS INC -- $43,211.56 3,182 BMZ4LN0
0.05% SVRA SAVARA INC -- $42,560.52 8,076 BYXGN81
0.05% ZBIO ZENAS BIOPHARMA INC -- $42,470.83 2,131 BQB42H3
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $42,347.98 6,586 BLR7H87
0.05% CMPS COMPASS PATHWAYS PLC -- $41,023.28 3,743 BMC3HS7
0.05% OMER OMEROS CORP -- $40,465.32 2,814 B4NB858
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $39,287.68 3,128 BJLKVS6
0.05% MNKD MANNKIND CORP -- $39,255.09 12,229 BF081J4
0.05% CGEM CULLINAN THERAPEUTICS INC -- $38,293.85 2,345 BM90J52
0.05% GRFS GRIFOLS SA-ADR -- $37,331.82 4,842 B8K7T65
0.05% PCRX PACIRA BIOSCIENCES INC -- $37,025.28 1,607 B3X26D8
0.05% XNCR XENCOR INC -- $36,038.18 2,911 BGCYWN8
0.05% GERN GERON CORP -- $35,726.58 25,338 2370381
0.05% DSGN DESIGN THERAPEUTICS INC -- $35,316.82 2,261 BMFK3H6
0.05% JANX JANUX THERAPEUTICS INC -- $35,283.15 2,415 BMFX8Y7
0.04% ORIC ORIC PHARMACEUTICALS INC -- $34,253.80 3,983 BKVDFF7
0.04% SANA SANA BIOTECHNOLOGY INC -- $33,833.60 10,573 BMFJJ97
0.04% TBPH THERAVANCE BIOPHARMA INC -- $33,523.37 2,011 BMNDK09
0.04% BIOA BIOAGE LABS INC -- $32,997.36 1,724 BT9K6D8
0.04% AMPH AMPHASTAR PHARMACEUTICALS IN -- $32,994.32 1,801 BNFWZS4
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $32,902.54 7,634 BZ0QMB7
0.04% ETON ETON PHARMACEUTICALS INC -- $32,792.48 1,064 BGL0JK3
0.04% KURA KURA ONCOLOGY INC -- $32,743.92 3,454 BYZD465
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $31,854.15 3,195 BFYQFJ2
0.04% ABSI ABSCI CORP -- $31,635.70 5,969 BN94K69
0.04% SPRY ARS PHARMACEUTICALS INC -- $31,431.24 3,924 BMCR7V2
0.04% ANNX ANNEXON INC -- $31,310.25 5,745 BMVV9R5
0.04% MESO MESOBLAST LTD- SPON ADR -- $30,608.94 2,078 BQS7491
0.04% ESPR ESPERION THERAPEUTICS INC -- $29,605.68 9,489 BBNBTD2
0.04% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $28,877.94 819 BL95N25
0.04% ZLAB ZAI LAB LTD-ADR -- $27,859.67 1,361 BD9GVY0
0.03% PSNL PERSONALIS INC -- $26,537.67 4,153 BJQ0608
0.03% VOR VOR BIOPHARMA INC -- $26,219.68 1,648 BRJJYT3
0.03% CADL CANDEL THERAPEUTICS INC -- $25,988.58 2,907 BP0TQC5
0.03% CTMX CYTOMX THERAPEUTICS INC -- $25,487.75 6,725 BYWVTY5
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $25,389.70 5,810 BMCWKZ2
0.03% ARVN ARVINAS INC -- $25,059.93 2,539 BDZ30Q0
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $24,853.20 2,235 BLFBZ32
0.03% KYTX KYVERNA THERAPEUTICS INC -- $24,449.04 2,268 BSMLR16
0.03% ACRS ACLARIS THERAPEUTICS INC -- $24,365.83 4,787 BYV2W40
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $23,816.96 6,472 B3MZ6K5
0.03% CRMD CORMEDIX INC -- $23,452.50 3,127 BJ0LT31
0.03% PRME PRIME MEDICINE INC -- $23,429.55 7,165 BPBJFM7
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $23,133.60 720 BQD3J33
0.03% SLDB SOLID BIOSCIENCES INC -- $22,818.96 3,092 BQHN6C7
0.03% TECX TECTONIC THERAPEUTIC INC -- $21,463.45 745 BPBPCG8
0.03% CSTL CASTLE BIOSCIENCES INC -- $21,417.00 1,180 BKLCWZ3
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $21,161.25 2,025 BKLXFX5
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $20,783.60 8,920 BFZNYB7
0.03% PRTA PROTHENA CORP PLC -- $20,515.20 2,137 B91XRN2
0.03% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $20,254.57 1,099 BS2CR64
0.03% AURA AURA BIOSCIENCES INC -- $20,218.42 2,521 BP81R42
0.03% RGNX REGENXBIO INC -- $20,170.36 2,009 BZ0G875
0.03% UPB UPSTREAM BIO INC -- $20,077.20 2,145 BRCFFK6
0.03% NGNE NEUROGENE INC -- $20,061.30 615 BS2F741
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $20,001.59 4,843 BYVQJ96
0.02% FULC FULCRUM THERAPEUTICS INC -- $19,169.00 2,644 BJDX8Z9
0.02% KMDA KAMADA LTD -- $17,999.40 2,290 B2Q9833
0.02% LRMR LARIMAR THERAPEUTICS INC -- $17,671.00 4,310 BMXNGZ6
0.02% REPL REPLIMUNE GROUP INC -- $17,368.10 3,277 BDDVW37
0.02% EOLS EVOLUS INC -- $17,290.56 2,573 BDRJH21
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $17,093.20 1,208 BPRBTY7
0.02% LXEO LEXEO THERAPEUTICS INC -- $16,686.72 2,897 BQ6C357
0.02% LKFT LAKEFRONT BIOTHERAPEUTIC-ADR -- $16,546.32 588 B292NQ7
0.02% LYEL LYELL IMMUNOPHARMA INC -- $16,219.32 843 BTNMG41
0.02% IVVD INVIVYD INC -- $16,170.00 11,000 BM8NHS1
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $16,162.56 1,152 B9L5200
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $15,512.40 4,309 BDFKQ07
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $15,223.49 11,987 B4N8MH9
0.02% VNDA VANDA PHARMACEUTICALS INC -- $15,084.78 2,346 B12W3P6
0.02% ALT ALTIMMUNE INC -- $15,012.42 4,971 BFY7DC4
0.02% KROS KEROS THERAPEUTICS INC -- $14,495.91 1,209 BM7V485
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $14,476.23 2,019 B7F2TY6
0.02% CCCC C4 THERAPEUTICS INC -- $14,252.64 3,873 BKX9NQ0
0.02% AVIR ATEA PHARMACEUTICALS INC -- $14,171.57 3,101 BLN9Z50
0.02% IMRX IMMUNEERING CORP - CLASS A -- $13,788.94 2,563 BMVBZF5
0.02% CABA CABALETTA BIO INC -- $13,717.39 3,821 BK5MWR1
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $13,615.02 7,962 BFMLGR4
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $13,010.72 1,864 BL5B6Z1
0.02% SIGA SIGA TECHNOLOGIES INC -- $12,249.02 2,842 2107437
0.02% NMRA NEUMORA THERAPEUTICS INC -- $11,804.96 6,632 BN4JN37
0.01% OABI OMNIAB INC -- $11,485.14 5,714 BN13S71
0.01% ACIU AC IMMUNE SA -- $11,340.12 3,993 BZC0D70
0.01% AVXL ANAVEX LIFE SCIENCES CORP -- $11,328.24 3,678 BYTYP72
0.01% EDIT EDITAS MEDICINE INC -- $11,237.50 3,875 BZ8FPH3
0.01% TRDA ENTRADA THERAPEUTICS INC -- $11,126.40 1,520 BP81RK8
0.01% CHRS COHERUS ONCOLOGY INC -- $10,115.77 5,933 BRK0149
0.01% LENZ LENZ THERAPEUTICS INC -- $9,998.10 1,242 BQV0J03
0.01% VYGR VOYAGER THERAPEUTICS INC -- $9,706.85 2,339 BY7RB53
0.01% FHTX FOGHORN THERAPEUTICS INC -- $9,695.25 2,325 BMF7DT9
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $9,355.60 1,231 BP2NYN2
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $9,317.28 1,128 BKC9SX3
0.01% NBP NOVABRIDGE BIOSCIENCES -- $9,132.75 4,455 BKRRKY7
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $9,098.46 2,241 BPRB2N7
0.01% CDXS CODEXIS INC -- $8,962.50 3,585 B5LL2C2
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $8,716.86 1,839 BKDQKM6
0.01% HUMA HUMACYTE INC -- $8,655.80 7,660 BMYTJP4
0.01% TKNO ALPHA TEKNOVA INC -- $8,308.75 2,125 BP7L561
0.01% TNYA TENAYA THERAPEUTICS INC -- $8,255.54 8,604 BNNXX52
0.01% CRBU CARIBOU BIOSCIENCES INC -- $7,865.20 3,710 BNYJR68
0.01% QSI QUANTUM-SI INC -- $7,214.00 7,762 BNR5QT9
0.01% LFCR LIFECORE BIOMEDICAL INC -- $6,691.50 1,487 2517058
0.01% PYXS PYXIS ONCOLOGY INC -- $6,474.02 2,471 BLBR8D5
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $6,466.46 2,261 BKTV702
0.01% MENS JYONG BIOTECH LTD -- $5,952.94 2,947 BPTK6Z2
0.01% AARD AARDVARK THERAPEUTICS INC -- $5,693.76 864 BTXQTX3
0.01% PEPG PEPGEN INC -- $4,857.62 2,729 BMTX3D7
0.01% RANI RANI THERAPEUTICS HOLDINGS-A -- $4,065.60 3,872 BNNXX18
-- GOSS GOSSAMER BIO INC -- $3,156.65 9,187 BJ0CK86
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
38.43% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 30,090,839 -- 4,991 --
27.14% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 21,246,266 -- 3,524 --
25.98% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 20,341,913 -- 3,374 --
20.32% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 15,910,584 -- 2,639 --
19.35% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 15,150,927 -- 2,513 --
4.87% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,816,370 -- 633 --
-- IQMM PROSHARES GENIUS MNY MKT ETF -- $5,004,500.00 50,000 BTGTPK8
-- -- NET OTHER ASSETS (LIABILITIES) -- $23,116,854.38 23,116,854 --

Index

as of 3/31/2026

  • Total Number of Companies256
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.50 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.